Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Answer questions and earn CME/CNE

[1]  M. Ewertz,et al.  Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark , 2009, Acta oncologica.

[2]  C. Bielajew,et al.  Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models , 2009, Journal of clinical and experimental neuropsychology.

[3]  F. Eustache,et al.  Baseline cognitive functions among elderly patients with localised breast cancer. , 2014, European journal of cancer.

[4]  Andrew J Saykin,et al.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Seok,et al.  Dysfunction of the neural network associated with sustained attention in cancer patients with clinically significant depressive symptoms , 2008, Neuroscience Letters.

[6]  R. Theriault,et al.  The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma , 2004, Cancer.

[7]  Lynette J. Epp,et al.  Executive function moderates the intention-behavior link for physical activity and dietary behavior , 2008, Psychology & health.

[8]  Wiro J Niessen,et al.  Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy , 2014, Human brain mapping.

[9]  M. Sitskoorn,et al.  Review of recent studies on interventions for cognitive deficits in patients with cancer , 2012, Expert review of anticancer therapy.

[10]  Salim S. Al-Rejaie,et al.  Metallothionein induction reduces caspase-3 activity and TNFα levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats , 2009, Oxidative medicine and cellular longevity.

[11]  A. Baddeley,et al.  Executive functions and self-regulation , 2012, Trends in Cognitive Sciences.

[12]  M. Galantino,et al.  Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series. , 2012, Explore.

[13]  J. Savard,et al.  Cognitive impairments associated with breast cancer treatments: results from a longitudinal study , 2009, Breast Cancer Research and Treatment.

[14]  Panagiotis Bamidis,et al.  The effects of a computer-based cognitive and physical training program in a healthy and mildly cognitive impaired aging sample , 2014, Aging & mental health.

[15]  H. Praag,et al.  Bridging animal and human models of exercise-induced brain plasticity , 2013, Trends in Cognitive Sciences.

[16]  T. Ahles,et al.  International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. , 2011, The Lancet. Oncology.

[17]  S. Schagen,et al.  Cognitive complaints after breast cancer treatments: Examining the relationship with neuropsychological test performance , 2014 .

[18]  J. Holland,et al.  Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study , 2006, Journal of the American Geriatrics Society.

[19]  J. Suls,et al.  New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors. , 2013, Journal of pain and symptom management.

[20]  A. Saykin,et al.  Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Irwin,et al.  The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer , 2013, Brain Imaging and Behavior.

[22]  J. de Vries,et al.  Subjective cognitive dysfunction in breast cancer patients: a systematic review , 2010, Psycho-oncology.

[23]  James N Laditka,et al.  Effect of Exercise on Cognitive Performance in Community‐Dwelling Older Adults: Review of Intervention Trials and Recommendations for Public Health Practice and Research , 2011, Journal of the American Geriatrics Society.

[24]  J. Fardell,et al.  Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research , 2011, Neuroscience & Biobehavioral Reviews.

[25]  Kim Wallen,et al.  Tamoxifen fails to affect central serotonergic tone but increases indices of anxiety in female rhesus macaques , 2005, Psychoneuroendocrinology.

[26]  Keith D. Cicerone,et al.  Persistent postconcussion syndrome: The structure of subjective complaints after mild traumatic brain injury , 1995 .

[27]  O. Tellingen,et al.  Chemotherapy-related cognitive dysfunction: current animal studies and future directions , 2013, Brain Imaging and Behavior.

[28]  Vincent A Magnotta,et al.  Frontal hypometabolism in elderly breast cancer survivors determined by [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study , 2015, International journal of geriatric psychiatry.

[29]  M. Lux,et al.  Cognitive function during neoadjuvant chemotherapy for breast cancer , 2007, Cancer.

[30]  V. Vijayanathan,et al.  Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist , 2011, Behavioural Brain Research.

[31]  I. Tannock,et al.  Cytokine levels in patients (pts) with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function , 2007 .

[32]  Denise C. Park,et al.  The aging mind: neuroplasticity in response to cognitive training , 2013, Dialogues in clinical neuroscience.

[33]  S. Kesler,et al.  Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy , 2013, Brain Imaging and Behavior.

[34]  N. Pachana,et al.  Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients , 2009, Journal of the International Neuropsychological Society.

[35]  D. Butterfield,et al.  2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. , 2011, Free radical biology & medicine.

[36]  Andrea Brovelli,et al.  Multivoxel Pattern Analysis for fMRI Data: A Review , 2012, Comput. Math. Methods Medicine.

[37]  J. Best,et al.  Improvements to executive function during exercise training predict maintenance of physical activity over the following year , 2014, Front. Hum. Neurosci..

[38]  Jean Alvarez,et al.  The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment , 2013, Integrative cancer therapies.

[39]  Arthur F Kramer,et al.  Exercise, cognition, and the aging brain. , 2006, Journal of applied physiology.

[40]  Camarin E. Rolle,et al.  Video game training enhances cognitive control in older adults , 2013, Nature.

[41]  J. Cuzick,et al.  Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). , 2008, The Lancet. Oncology.

[42]  Olaf Sporns,et al.  THE HUMAN CONNECTOME: A COMPLEX NETWORK , 2011, Schizophrenia Research.

[43]  M. Tuzcu,et al.  Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats , 2008, Neuroscience.

[44]  Constance Steinkuehler,et al.  Games, Learning and Society , 2009 .

[45]  Gerd Kempermann,et al.  Why and How Physical Activity Promotes Experience-Induced Brain Plasticity , 2010, Front. Neurosci..

[46]  J. Vasey,et al.  Employment pathways in a large cohort of adult cancer survivors , 2005, Cancer.

[47]  D. Correa,et al.  Cognitive function and quality of life in ovarian cancer. , 2012, Gynecologic oncology.

[48]  William J Jagust,et al.  Estrogen- and tamoxifen-associated effects on brain structure and function , 2004, NeuroImage.

[49]  Cathy R. Cox,et al.  Tai Chi effects on neuropsychological, emotional, and physical functioning following cancer treatment: a pilot study. , 2012, Complementary therapies in clinical practice.

[50]  Sanne B. Schagen,et al.  Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release , 2010, Behavioural Brain Research.

[51]  J. Weis,et al.  Effects of Specific Neuropsychological Training Programs for Breast Cancer Patients After Adjuvant Chemotherapy , 2009, Journal of psychosocial oncology.

[52]  Rebecca Elliott,et al.  Executive functions and their disorders. , 2003, British medical bulletin.

[53]  Andrew J. Saykin,et al.  Candidate mechanisms for chemotherapy-induced cognitive changes , 2007, Nature Reviews Cancer.

[54]  Michelle Monje,et al.  Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis , 2012, Behavioural Brain Research.

[55]  L. Gottschalk,et al.  The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. , 2003, Methods and findings in experimental and clinical pharmacology.

[56]  C. Bielajew,et al.  The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study , 2008, Psycho-oncology.

[57]  D. Correa,et al.  Neurocognitive Changes in Cancer Survivors , 2008, Cancer journal.

[58]  P. Nathan,et al.  Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2011, European Journal of Cancer.

[59]  F. Joly,et al.  Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: Role of glucose as adjuvant , 2014, Neuropharmacology.

[60]  J. Abraham,et al.  Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats , 2008, Metabolic Brain Disease.

[61]  C. Heckler,et al.  YOCAS yoga, fatigue, memory difficulty, and quality of life: Results from a URCC CCOP randomized, controlled clinical trial among 358 cancer survivors. , 2012 .

[62]  Douglas C. Noll,et al.  Prechemotherapy alterations in brain function in women with breast cancer , 2010, Journal of clinical and experimental neuropsychology.

[63]  J. Kramer,et al.  Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide , 2008, Psycho-oncology.

[64]  Santosh Mathan,et al.  Towards an index of cognitive efficacy EEG-based estimation of cognitive load among individuals experiencing cancer-related cognitive decline , 2010, 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology.

[65]  C. Brayne,et al.  Association between APOE genotype, neuropathology and dementia in the older population of England and Wales , 2011, Neuropathology and applied neurobiology.

[66]  S. Kesler,et al.  Multivariate Pattern Analysis of fMRI in Breast Cancer Survivors and Healthy Women , 2013, Journal of the International Neuropsychological Society.

[67]  Andra M. Smith,et al.  Persistent Cognitive Changes in Breast Cancer Patients 1 Year Following Completion of Chemotherapy , 2013, Journal of the International Neuropsychological Society.

[68]  Fredric D. Wolinsky,et al.  A Randomized Controlled Trial of Cognitive Training Using a Visual Speed of Processing Intervention in Middle Aged and Older Adults , 2013, PloS one.

[69]  Andrew J Saykin,et al.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  J. Kaiser,et al.  Challenges in research on the neural basis of „chemobrain” , 2014 .

[71]  Susanne M. Jaeggi,et al.  The role of individual differences in cognitive training and transfer , 2014, Memory & cognition.

[72]  Paula I. Moreira,et al.  Physical exercise as a possible strategy for brain protection: Evidence from mitochondrial-mediated mechanisms , 2012, Progress in Neurobiology.

[73]  K. Campbell,et al.  Review of exercise studies in breast cancer survivors: attention to principles of exercise training. , 2012, British journal of sports medicine.

[74]  J. Ibrahim,et al.  Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. , 2014, Journal of the National Cancer Institute.

[75]  K. Ball,et al.  Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial. , 2010, European journal of cancer care.

[76]  R. Rhodes,et al.  Implementation Intentions for Physical Activity Behavior in Older Adult Women: An Examination of Executive Function as a Moderator of Treatment Effects , 2014, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[77]  V. Shilling,et al.  Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. , 2007, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[78]  S. Allan,et al.  A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer , 2006, British Journal of Cancer.

[79]  T. Di Paolo,et al.  Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. , 2003, Brain research. Molecular brain research.

[80]  Marie Chupin,et al.  Breast Cancer Affects Both the Hippocampus Volume and the Episodic Autobiographical Memory Retrieval , 2011, PloS one.

[81]  K Nalini,et al.  Hippocampal brain amines in methotrexate-induced learning and memory deficit. , 2002, Canadian journal of physiology and pharmacology.

[82]  Richard E. Harris,et al.  Preliminary differences in peripheral immune markers and brain metabolites between fatigued and non-fatigued breast cancer survivors: a pilot study , 2013, Brain Imaging and Behavior.

[83]  A. Leemans,et al.  Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  S. M. Hadi Hosseini,et al.  Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors , 2012, Neurobiology of Disease.

[85]  M. Noble,et al.  Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[86]  C. Gundy,et al.  Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  Salma K. Marani,et al.  A prospective study of cognitive function in men with non‐seminomatous germ cell tumors , 2014, Psycho-oncology.

[88]  S. Sereika,et al.  Cognitive impairment associated with adjuvant therapy in breast cancer , 2006, Psycho-oncology.

[89]  J. Fardell,et al.  Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity , 2011, Psychopharmacology.

[90]  Shelli R. Kesler,et al.  Prevalence, mechanisms, and management of cancer-related cognitive impairment , 2014, International review of psychiatry.

[91]  V. Shilling,et al.  The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. , 2005, Breast.

[92]  G. Winocur,et al.  Chemotherapy and Cognitive Impairment: Treatment Options , 2011, Clinical pharmacology and therapeutics.

[93]  R. Hindges,et al.  Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. , 2014, Neuro-oncology.

[94]  L. Ercoli,et al.  Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints , 2013, Brain Imaging and Behavior.

[95]  Sven Haller,et al.  Real-time fMRI neurofeedback: Progress and challenges , 2013, NeuroImage.

[96]  Felipe Fregni,et al.  Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer's disease , 2011, Neuropsychological rehabilitation.

[97]  T. L. Briones,et al.  Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling , 2014, Journal of Neuroinflammation.

[98]  Andra M. Smith,et al.  Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study , 2012, Journal of clinical and experimental neuropsychology.

[99]  B. Oh,et al.  Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial , 2012, Supportive Care in Cancer.

[100]  L. Fallowfield,et al.  The effects of hormone therapy on cognition in breast cancer , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[101]  P. Reuter-Lorenz,et al.  Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation , 2014, Breast Cancer Research and Treatment.

[102]  Paul A. Newhouse,et al.  Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study , 2013, Brain Imaging and Behavior.

[103]  Myrle M. Stouten-Kemperman,et al.  Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type , 2014, Brain Imaging and Behavior.

[104]  J. Vardy.  Cognitive function in breast cancer survivors. , 2009, Cancer treatment and research.

[105]  A. Piga,et al.  Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study. , 2008, Critical reviews in oncology/hematology.

[106]  D. Veltman,et al.  Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer , 2011, Human brain mapping.

[107]  Andrew J. Saykin,et al.  Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage , 2012, Breast Cancer Research and Treatment.

[108]  Perminder Sachdev,et al.  Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[109]  H. Blake.  Physical activity and exercise in the treatment of depression , 2012, Front. Psychiatry.

[110]  Michael E. Phelps,et al.  Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy , 2007, Breast Cancer Research and Treatment.

[111]  H. Hamburger,et al.  Electrophysiological Correlates of Information Processing in Breast-Cancer Patients Treated With Adjuvant Chemotherapy , 2005, Breast Cancer Research and Treatment.

[112]  Andra M. Smith,et al.  Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study , 2012, Brain Imaging and Behavior.

[113]  Mark Noble,et al.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system , 2008, Journal of biology.

[114]  M. Perry,et al.  Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer , 2010, Psycho-oncology.

[115]  E. McAuley,et al.  Self-regulatory processes and exercise adherence in older adults: executive function and self-efficacy effects. , 2011, American journal of preventive medicine.

[116]  N. Naghdi,et al.  Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats , 2006, Behavioural Brain Research.

[117]  A. Mechelli,et al.  Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review , 2012, Neuroscience & Biobehavioral Reviews.

[118]  P. Sismondi,et al.  Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. , 2012, European journal of cancer care.

[119]  A. Howell,et al.  Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study , 2004, Psycho-oncology.

[120]  Ronald C Petersen,et al.  Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. , 2011, Mayo Clinic proceedings.

[121]  M. Muller,et al.  Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. , 2006, Journal of the National Cancer Institute.

[122]  M. Jorge Cardoso,et al.  Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment☆ , 2013, NeuroImage: Clinical.

[123]  J. Myers.  Chemotherapy-related cognitive impairment: the breast cancer experience. , 2012, Oncology nursing forum.

[124]  M. Verfaellie,et al.  Chronic Postconcussion Symptoms and Functional Outcomes in OEF/OIF Veterans with Self-Report of Blast Exposure , 2012, Journal of the International Neuropsychological Society.

[125]  Alexander Leemans,et al.  Chemotherapy‐induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients , 2011, Human brain mapping.

[126]  J. Simon,et al.  White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. , 1998, AJNR. American journal of neuroradiology.

[127]  L. Ercoli,et al.  Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study , 2014, Psycho-oncology.

[128]  A. Saykin,et al.  Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates , 2013, Brain Imaging and Behavior.

[129]  A. Saykin,et al.  Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial , 2012, Psycho-oncology.

[130]  M. Cyr,et al.  Modulation by Estrogen-Receptor Directed Drugs of 5-Hydroxytryptamine-2A Receptors in Rat Brain , 2000, Neuropsychopharmacology.

[131]  R. Theriault,et al.  ‘Chemobrain’ in breast carcinoma? , 2004, Cancer.

[132]  M. Breteler,et al.  Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia. , 2013, Critical reviews in oncology/hematology.

[133]  Scott M. Hayes,et al.  A review of cardiorespiratory fitness-related neuroplasticity in the aging brain , 2013, Front. Aging Neurosci..

[134]  I. Tannock,et al.  Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[135]  L. von Koch,et al.  The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis , 2012, Multiple sclerosis.

[136]  P. Ganz,et al.  Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen , 2004, Journal of clinical and experimental neuropsychology.

[137]  Lynette J. Tippett,et al.  The virtual brain: 30 years of video-game play and cognitive abilities , 2013, Front. Psychol..

[138]  S M Hadi Hosseini,et al.  Altered small-world properties of gray matter networks in breast cancer , 2012, BMC Neurology.

[139]  Oxana Palesh,et al.  Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors , 2013, Brain, Behavior, and Immunity.

[140]  H. Green,et al.  A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life , 2013, Psycho-oncology.

[141]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[142]  C. Cleeland,et al.  Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant , 2013, Cancer.

[143]  Ruth O'Hara,et al.  Prefrontal cortex and executive function impairments in primary breast cancer. , 2011, Archives of neurology.

[144]  M. Perry,et al.  Cognitive and Psychological Factors Associated with Early Posttreatment Functional Outcomes in Breast Cancer Survivors , 2009, Journal of psychosocial oncology.

[145]  P. Ganz,et al.  Neuropsychological studies in breast cancer: in search of chemobrain , 2009, Breast Cancer Research and Treatment.

[146]  Katharina S Sunnerhagen,et al.  Can computerized working memory training improve impaired working memory, cognition and psychological health? , 2013, Brain injury.

[147]  T. Foster,et al.  Daily exercise improves memory, stimulates hippocampal neurogenesis and modulates immune and neuroimmune cytokines in aging rats , 2013, Brain, Behavior, and Immunity.

[148]  Andrew J Saykin,et al.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[149]  Andrew J. Saykin,et al.  Cognitive function in breast cancer patients prior to adjuvant treatment , 2008, Breast Cancer Research and Treatment.

[150]  Yutaka Matsuoka,et al.  Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy , 2007, Cancer.

[151]  H. Weiss,et al.  Neurotoxicity of commonly used antineoplastic agents (second of two parts). , 1974, The New England journal of medicine.

[152]  N. Bayraktar,et al.  Oxidant/antioxidant Parameters and their Relationship with Chemotherapy in Hodgkin's Lymphoma , 2005, The Journal of international medical research.

[153]  A. Saykin,et al.  Breast cancer chemotherapy-related cognitive dysfunction. , 2002, Clinical breast cancer.

[154]  Daniel M. Curlik,et al.  Training your brain: Do mental and physical (MAP) training enhance cognition through the process of neurogenesis in the hippocampus? , 2013, Neuropharmacology.

[155]  H. Hamburger,et al.  ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy , 2008, Clinical Neurophysiology.

[156]  Brigitte Röder,et al.  Beneficial effects of physical exercise on neuroplasticity and cognition , 2013, Neuroscience & Biobehavioral Reviews.

[157]  M. Hoane,et al.  Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury , 2006, Behavioural Brain Research.

[158]  G. Sarty,et al.  A social neuroscience perspective on physical activity. , 2008, Journal of sport & exercise psychology.

[159]  Vered Stearns,et al.  Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[160]  Andra M. Smith,et al.  Pre-Chemotherapy Differences in Visuospatial Working Memory in Breast Cancer Patients Compared to Controls: An fMRI Study , 2011, Front. Hum. Neurosci..

[161]  Wiro J. Niessen,et al.  Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy , 2012, Breast Cancer Research and Treatment.

[162]  Chunfu Wu,et al.  Tamoxifen and toremifene cause impairment of learning and memory function in mice , 2002, Pharmacology Biochemistry and Behavior.

[163]  Willem Boogerd,et al.  Late effects of high‐dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging , 2012, Human brain mapping.

[164]  A. Saykin,et al.  Cognitive‐behavioral management of chemotherapy‐related cognitive change , 2007, Psycho-oncology.

[165]  Sheng Zhang,et al.  Effects of androgen deprivation on brain function in prostate cancer patients – a prospective observational cohort analysis , 2012, BMC Cancer.

[166]  D. Michelson,et al.  Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques , 2002, Psychoneuroendocrinology.

[167]  S. Rodenhuis,et al.  Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[168]  P. Calabresi,et al.  Neural 17β-estradiol facilitates long-term potentiation in the hippocampal CA1 region , 2011, Neuroscience.

[169]  C. Miaskowski,et al.  Changes in perceived attentional function in women following breast cancer surgery , 2011, Breast Cancer Research and Treatment.

[170]  A. Saykin,et al.  Altered Cerebral Blood Flow One Month after Systemic Chemotherapy for Breast Cancer: A Prospective Study Using Pulsed Arterial Spin Labeling MRI Perfusion , 2014, PloS one.

[171]  K. Boone,et al.  The effects of tamoxifen and estrogen on brain metabolism in elderly women. , 2002, Journal of the National Cancer Institute.

[172]  P. Wigmore,et al.  Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil , 2010, Behavioural Brain Research.

[173]  Stephanie Cajigal.  Health Insurers Deny Coverage for Cognitive Rehabilitation , 2007 .

[174]  Gwyn McClelland.  Survivors , 1891, The Hospital.

[175]  S. Willis,et al.  A randomized trial of cognitive rehabilitation in cancer survivors. , 2013, Life sciences.

[176]  J. Abraham,et al.  Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors , 2011, Expert review of anticancer therapy.

[177]  T. L. Briones,et al.  RETRACTED: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment , 2015, Behavioural Brain Research.

[178]  Andrew J. Saykin,et al.  Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study , 2013, Brain, Behavior, and Immunity.

[179]  Corson N. Areshenkoff,et al.  An empirical comparison of the therapeutic benefits of physical exercise and cognitive training on the executive functions of older adults: a meta-analysis of controlled trials. , 2014, Neuropsychology.

[180]  Y. Levkovitz,et al.  Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD Subjects: A randomized controlled pilot study , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[181]  P. Sachdev,et al.  Prevalence and predictors of “subjective cognitive complaints” in the Sydney Memory and Ageing Study. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[182]  Neil B. Niman.  The Allure of Games , 2013 .

[183]  S. Kesler.  Default mode network as a potential biomarker of chemotherapy-related brain injury , 2014, Neurobiology of Aging.

[184]  M. Dodd,et al.  A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients , 2011, Supportive Care in Cancer.

[185]  J. de Vries,et al.  Chemotherapy and cognitive complaints in women with breast cancer , 2013, Psycho-oncology.

[186]  H. Weiss,et al.  Neurotoxicity of commonly used antineoplastic agents (first of two parts). , 1974, The New England journal of medicine.

[187]  L. Carlson,et al.  Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls , 2008, Journal of cancer survivorship : research and practice.

[188]  Andra M. Smith,et al.  Cognitive effects of chemotherapy in breast cancer patients: a dose–response study , 2013, Psycho-oncology.

[189]  M. Wieneke,et al.  Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer , 1995 .

[190]  Daoqiang Zhang,et al.  Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease , 2012, NeuroImage.

[191]  J. VanMeter,et al.  Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? , 2013, Seminars in Oncology.

[192]  Sung-Ho Kim,et al.  Hippocampal dysfunctions in tumor-bearing mice , 2014, Brain, Behavior, and Immunity.

[193]  T. Simuni,et al.  Capecitabine-induced multifocal leukoencephalopathy: A report of five cases , 2005, Neurology.

[194]  D. Mohr,et al.  Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. , 2010, Neuropsychology.

[195]  Gerd Kempermann,et al.  Additive Effects of Physical Exercise and Environmental Enrichment on Adult Hippocampal Neurogenesis in Mice , 2009, Front. Neurogenesis.

[196]  K. Chamari,et al.  Improvement of cognitive function by mental and/or individualized aerobic training in healthy elderly subjects. , 2002, International journal of sports medicine.

[197]  M. Irwin,et al.  Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? , 2013, Brain, Behavior, and Immunity.

[198]  A. Saykin,et al.  Advanced cognitive training for breast cancer survivors: a randomized controlled trial , 2012, Breast Cancer Research and Treatment.

[199]  K. Hermelink.  Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer , 2011, Cancer.

[200]  C. Jansen,et al.  Coping strategies and interventions for cognitive changes in patients with cancer. , 2013, Seminars in oncology nursing.

[201]  S. Ancoli-Israel,et al.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. , 2013, Journal of the National Cancer Institute.

[202]  Oxana Palesh,et al.  Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. , 2013, Clinical breast cancer.

[203]  R. Peeters,et al.  Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[204]  Mark Noble,et al.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo , 2006, Journal of biology.

[205]  R. Schmidt,et al.  Cancer therapy-associated CNS neuropathology: an update and review of the literature , 2006, Acta Neuropathologica.

[206]  S. Rodenhuis,et al.  Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.

[207]  A. Saykin,et al.  Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[208]  C. Gundy,et al.  Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[209]  D. Ronis,et al.  Pre‐treatment factors related to cognitive functioning in women newly diagnosed with breast cancer , 2005, Psycho-oncology.

[210]  R. Gelber,et al.  Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. , 2010, Breast.

[211]  P. Maruff,et al.  Postoperative Cognitive Dysfunction Is Independent of Type of Surgery and Anesthetic , 2011, Anesthesia and analgesia.

[212]  Á. Pascual-Leone,et al.  Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? , 2013, Neuropharmacology.

[213]  Sanne B. Schagen,et al.  Chemotherapy-Related Cognitive Dysfunction , 2012, Current Neurology and Neuroscience Reports.

[214]  P. Jacobsen,et al.  Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early‐stage breast carcinoma , 2005, Cancer.

[215]  Andrew J. Saykin,et al.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study , 2010, Breast Cancer Research and Treatment.

[216]  G. McDougall,et al.  Symptom management of affective and cognitive disturbance with a group of cancer survivors. , 2011, Archives of psychiatric nursing.

[217]  I. Haimov,et al.  Cognitive Training Improves Sleep Quality and Cognitive Function among Older Adults with Insomnia , 2013, PloS one.

[218]  Hiroto Kuwabara,et al.  Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. , 2008, Clinical breast cancer.

[219]  Bruce Luber,et al.  Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS) , 2014, NeuroImage.

[220]  Fumiko Hoeft,et al.  OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 110 ( 28 ) ISSN 0027-8424 , 2013 .

[221]  E. Tanenbaum,et al.  Memantine Protects Rats Treated with Intrathecal Methotrexate from Developing Spatial Memory Deficits , 2013, Clinical Cancer Research.

[222]  S. Kesler,et al.  Cognitive profile of Turner syndrome. , 2009, Developmental disabilities research reviews.

[223]  S. Mohile,et al.  An update on cancer- and chemotherapy-related cognitive dysfunction: current status. , 2011, Seminars in oncology.

[224]  M. El-Tamer,et al.  The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study , 2010, Breast Cancer Research and Treatment.

[225]  T. Salthouse.  Neuroanatomical substrates of age-related cognitive decline. , 2011, Psychological bulletin.

[226]  S. Subramanian,et al.  Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response , 2009, Journal of cancer survivorship : research and practice.

[227]  M. Csíkszentmihályi,et al.  The Importance of Challenge for the Enjoyment of Intrinsically Motivated, Goal-Directed Activities , 2012, Personality & social psychology bulletin.

[228]  Yaakov Stern,et al.  Cognitive Reserve: Implications for Assessment and Intervention , 2013, Folia Phoniatrica et Logopaedica.

[229]  Alice J. O'Toole,et al.  Theoretical, Statistical, and Practical Perspectives on Pattern-based Classification Approaches to the Analysis of Functional Neuroimaging Data , 2007, Journal of Cognitive Neuroscience.

[230]  T. Ahles,et al.  Brain vulnerability to chemotherapy toxicities , 2012, Psycho-oncology.

[231]  D. Silverman,et al.  The effect of aromatase inhibition on the cognitive function of older patients with breast cancer. , 2014, Clinical breast cancer.

[232]  M. Mehlsen,et al.  Long-term cognitive function following chemotherapy in patients with testicular cancer , 2009, Journal of the International Neuropsychological Society.

[233]  Brigitte Röder,et al.  Cardiovascular fitness modulates brain activation associated with spatial learning , 2012, NeuroImage.

[234]  Andrea Chincarini,et al.  Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease , 2011, NeuroImage.